v3.25.1
Investment in equity investees (Details 6)
¥ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2024
CNY (¥)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
CNY (¥)
Dec. 31, 2022
CNY (¥)
Dec. 31, 2024
USD ($)
Operating data:          
Net income/(loss) ¥ 44,660 $ 6,118 ¥ 23,257 ¥ 9,691  
Balance sheet data:          
Current assets 386,698   307,810   $ 52,977
Non-current assets 311,536   321,148   42,681
Current liabilities 299,521   265,650   41,034
Non-current liabilities 85,416   66,928   11,702
Non-controlling interests 73,466   63,908   $ 10,065
Share of results of equity investees          
Equity method investments          
Impairment charges in connection with the equity method 699   266 1,316  
Equity Method Investments          
Operating data:          
Revenues 146,583   149,237 160,554  
Gross profit 70,000   48,134 47,369  
Income/(loss) from operations 8,334   (274) (2,158)  
Net income/(loss) 4,380   (1,733) (1,583)  
Net income/(loss) attributable to the investees' ordinary shareholders 4,641   (1,506) ¥ (1,327)  
Balance sheet data:          
Current assets 161,218   155,283    
Non-current assets 146,848   145,171    
Current liabilities 124,013   118,886    
Non-current liabilities 44,090   50,228    
Redeemable stock 28,167   0    
Non-controlling interests ¥ 4,429   ¥ 359